Ctic stock earnings
WebApr 6, 2024 · The CTI BioPharma stock price gained 3.68% on the last trading day (Thursday, 6th Apr 2024), rising from $4.08 to $4.23. During the last trading day the stock fluctuated 7.99% from a day low at $4.01 to a day high of $4.33. The price has fallen in 5 of the last 10 days and is down by -1.63% for this period. Volume has increased on the last … Web2 days ago · Get the latest CTI BioPharma Corp CTIC detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. ... In fact, when combining a Zacks Rank #3 or …
Ctic stock earnings
Did you know?
WebApr 3, 2024 · CTIC Complete CTI BioPharma Corp. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. WebCTI BioPharma Corp. analyst ratings, historical stock prices, earnings estimates & actuals. CTIC updated stock price target summary.
WebApr 9, 2024 · 6 brokers have issued 12 month price targets for CTI BioPharma's shares. Their CTIC share price forecasts range from $9.00 … WebCti Biopharm (CTIC) reports earnings on 6/5/2024. Shares are down 15.5% since reporting last quarter. The Earnings Whisper Score gives the statistical odds for the stock ahead …
Web1 day ago · CTI BioPharma Corp. (Nasdaq: CTIC), a commercial biopharmaceutical company focused on the development and commercialization of novel targeted therapies for blood-related cancers, today announced ... WebApr 7, 2024 · CTI BioPharma Corp’s trailing 12-month revenue is $53.9 million with a -172.4% profit margin. Year-over-year quarterly sales growth most recently was %. …
WebMar 28, 2024 · CTI BioPharma Corp. (CTIC) latest earnings report: revenue, EPS, surprise, history, news and analysis.
WebApr 10, 2024 · CTIC Stock Overview. CTI BioPharma Corp., a biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel targeted therapies for blood-related cancers in the United States. ... Earnings-US$92.99m: Last Reported Earnings. Dec 31, 2024. Next Earnings Date. n/a. Earnings per share (EPS)-0.71: … incheon waspWebCTIC Stock Price - CTI BioPharma Corp. is a biopharmaceutical company, which engages in the development, acquisition, and commercialization of novel targeted therapies for blood-related cancers. ... The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the ... incoming call soundWebApr 12, 2024 · While ratings are subjective and will change, the latest CTI BioPharma ( CTIC) rating was a reiterated with a price target of $0.00 to $9.00. The current price CTI … incheon vs seoulWeb1 day ago · CTI BioPharma Corp. (Nasdaq: CTIC), a commercial biopharmaceutical company focused on the development and commercialization of novel targeted therapies … incoming call screen androidWeb1 day ago · CTI BioPharma (CTIC) delivered earnings and revenue surprises of -5.71% and 6.74%, respectively, for the quarter ended March 2024. Do the numbers hold clues to … incoming call softwareWebOn Mar 06, 2024, Cti Biopharma ( NASDAQ: CTIC) reported Q4 2024 earnings per share (EPS) of -$0.12, up 69.23% year over year. Total Cti Biopharma earnings for the quarter were -$17.46 million. In the same quarter last year, Cti Biopharma 's earnings per share (EPS) was -$0.39. If you're new to stock investing, here's how to buy Cti Biopharma stock. incheon vs gimpo airportWebApr 4, 2024 · The technique has proven to be very useful for finding positive surprises. In fact, when combining a Zacks Rank #3 or better and a positive Earnings ESP, stocks produced a positive surprise 70% of ... incoming call tracking software for pc